Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

1018 oligonucleotide

Known as: CpG-B ISS-ODN, ISS 1018 CpG ODN, 1018 ISS 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
ABSTRACT Targeting transcription factors represents one possibility to interfere with a known activated regulatory pathway that… Expand
  • table 1
  • table 2
Review
2013
Review
2013
Hepatitis B (HBV) virus infects the liver, and upon chronic infection, can cause liver cirrhosis and hepatocellular carcinoma… Expand
2008
2008
(+)-Dapoxetine hydrochloride, (R)-Etodolac; Abatacept, ABT-510, Adalimumab, Agatolimod sodium, Alemtuzumab, Alvocidib… Expand
2008
2008
(-)-Epigallocatechin gallate, (-)-Gossypol; Ad.hIFN-beta, AF-37702, Agatolimod sodium, Agomelatine, Alvocidib hydrochloride, ARC… Expand
2005
2005
Gateways to Clinical Trials are a guide to the most recent clinical trials in the current literature and congresses. The data in… Expand
2005
2005
We propose a mechanism for oligonucleotide (ODN) release from cationic lipid complexes in cells that accounts for various… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
2005
2005
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
2004
2004
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
2002
2002
Since antisense oligodeoxynucleotides (AS-ODNs) have been recognized as a new generation of putative therapeutic agents, we… Expand